<DOC>
	<DOCNO>NCT01889914</DOCNO>
	<brief_summary>The aim TRICIDIA2 study compare two modality administration insulin . In future study , investigator wish study treatment continuous infusion insulin improve insulinosensitivity type 2 diabetic patient ; investigator indeed expect insulin deliver continuous way decrease insulino-resistance patient compare intermittent deliver insulin .</brief_summary>
	<brief_title>TReatment Insulin Continuous Infusion Type 2 DIAbetes</brief_title>
	<detailed_description>We wish use treatment classic tool measure insulinosensitivity / euglycemic hyperinsulinemic clamp associate measure insulinosecretion thanks test load glucose IV . The coupling procedure 2 test Botnia clamp . We also wish use continuous measure subcutaneous glucose several day estimate reduction average glycemia fast prandial period well decrease time spent hyperglycemia day . This tool demonstrate interest type 2 diabetic population several study . Finally current / spectro-IRM method image validate quantify measure exactly importance steatosis , include type 2 patient , know probably result insulino-resistance ; We would also like demonstrate genetic polymorphism protein ( polymorphisms G / T493 MTP , 1927 C/T receiver R1 adiponectin 265 C/T gene Apolipoprotéines A ) factor modulate steatosis development case type 2 diabetes . In secondary criterion wait improvement HbA1c , quality life type 2 obese people regard treatment intensified Multi-injections .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>age &gt; 18 year old type 2 diabete patient insuline basal/bolus treatment least 6 month Doses insuline &gt; 0,7 U/Kg/j HbA1c ≥ 7,5 % without ADO least 4 week ( sulfamides , Incrétines , glinides , acarbose ) except metformine BMI ≥ 28,5 kg/m² clinical diagnostique diabetes least 10 an Patient must able Realize automonitoring manage functioning insulin pump . glitazone treatment le 3 month inclusion Patient untreated laser proliferative ischemic retinopathy BMI &lt; 28,5 kg/m² Pacemaker ( CI IRM ) Presence implantable material ( CI IRM ) Pregnancy , breastfeed Practices violent sport Professional extreme environment cold heat Serious psychiatric disease physical and/or psychiatric Incapacitated medically significant Poor sanitation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>